Global Update: A new COVID-19 variant, BA.3.2, informally nicknamed “Cicada”, is being tracked by health authorities after its spread was reported in multiple countries, including the United States. According to recent data referenced by health agencies, the variant has been identified in at least 23 countries, raising attention among public health experts.
However, experts emphasize that while the variant is being monitored, there is no immediate evidence suggesting increased severity compared to earlier Omicron subvariants.
Symptoms Remain Similar to Omicron
Medical reports indicate that symptoms associated with the BA.3.2 variant largely mirror those seen in the Omicron family. Common symptoms include:
- Sore throat and cough
- Fever and fatigue
- Headache and muscle pain
- Nasal congestion
- Loss of taste or smell
- Nausea and diarrhoea
- Shortness of breath (in some cases)
Doctors note that most cases reported so far appear to be mild to moderate, particularly among vaccinated individuals.
Global Monitoring and WHO Position
Health agencies, including the Centers for Disease Control and Prevention (CDC) and global surveillance networks, are closely tracking the variant’s spread. As of now, the variant has not been classified as a Variant of Concern, but remains under observation due to its presence across multiple regions.
The World Health Organization (WHO) continues to monitor emerging subvariants as part of its routine genomic surveillance, especially those within the Omicron lineage.
Social Media Buzz vs Reality
The emergence of the “Cicada” variant has triggered mixed reactions online. While some posts have raised alarm, others have dismissed the situation as exaggerated. Experts warn against misinformation and stress the importance of relying on verified public health updates.
Health professionals caution that viral social media narratives can often amplify fear without scientific backing. They advise the public to follow updates from official sources rather than unverified claims.
What It Means for India
For India, health authorities are maintaining routine surveillance of COVID-19 variants through genome sequencing and monitoring of international trends. So far, there is no indication of a major surge linked to this variant in the country.
Experts highlight that India’s previous exposure to multiple Omicron waves, along with vaccination coverage, provides a level of population immunity that may help limit severe outcomes.
Precaution Still Advised
While there is no cause for panic, doctors recommend continuing basic precautions such as:
- Maintaining hygiene
- Wearing masks in crowded spaces if symptomatic
- Staying updated on vaccinations
- Testing in case of symptoms
Experts conclude that the situation remains under control globally, but continued monitoring is essential as the virus evolves.
Bottom Line: The BA.3.2 “Cicada” variant is spreading across countries but currently appears to behave similarly to earlier Omicron strains, with no confirmed evidence of higher severity.
